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Background: Non-steroid anti-inflammatory drugs (NSAIDs) have been proposed as part of a multimodal
postoperative analgesia in patients operated for colorectal cancer. However, whether these drugs are prescribed
and taken by the patients have not been evaluated. The aim of this study was to quantify the postoperative use of
NSAIDs in these patients.
Methods: Data from patients operated for colorectal cancer between January 1, 2006 and December 31, 2009 were
collected from the Danish Colorectal Cancer Group’s (DCCG) prospective database. From the electronically registered
medical records, data for the use of the two NSAIDs diclofenac and ibuprofen were recorded. The data from six
colorectal departments in eastern Denmark were compared.
Results: Of the 2,754 patients analyzed overall, 40.6% received NSAIDs as part of their analgesic treatment. The
percentage of the patients receiving NSAIDs, receiving a pre-defined dosage as a minimum and receiving NSAIDs as
p.r.n. medication, and the type of NSAID were significantly different both between department and within departments.
The median dose of ibuprofen and diclofenac were 1200 mg (400–2,400 mg) and 100 mg (50–200 mg), respectively.
Conclusions: The large variation between and within the departments points to an inconsistency in the use of
multimodal post-operative pain treatments. This may be a result of insufficient evidence on procedure specific pain
treatments and possibly a lack of compliance to existing guidelines. High-quality large-scale studies are warranted to
form the basis for guidelines for postoperative analgesic treatment.
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Pain treatmentBackground
In spite of much international focus on postoperative
pain treatment, 86–89% of patients still experience moder-
ate to severe pain after surgery [1,2]. Hence, postoperative
pain management requires optimization. A solution may
be the use of multimodal postoperative analgesia, which
reduces opioid related side effects [3-5]. As part of such
treatment, non-steroid anti-inflammatory drugs (NSAIDs)
are often advocated as an important component [3].* Correspondence: hcpommergaard@gmail.com
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article, unless otherwise stated.However, surgeons may be reluctant to use NSAID due to
concerns about side effects. Our hypothesis was that
NSAIDs may not be prescribed or actually taken by the
patients as part of a multimodal post-operative analgesic
regimen. This has not been evaluated for colorectal surgery
and it remains unclear whether consensus exists between
departments regarding this treatment.
The aim of this study was to evaluate the type, dosage
and extent of NSAIDs used at six major colorectal
surgery centers in eastern Denmark, together comprising
39% of the total number of operations performed in the
country [6].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Demographic data for the included patients
Age, median (range) 70 (22–97)
Gender (males/females) 52.3%/47.7%
ASA-class 23.4% (1), 60.2% (2), 15.7% (3), 0.7% (4)
ASA: American Society of Anesthesiologists.
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Data from patients operated for colorectal cancer between
January 1, 2006 and December 31, 2009 were collected
from the Danish Colorectal Cancer Group’s (DCCG) pro-
spective database, which has a national data completeness
rate of 99% [7]. To evaluate the analgesics prescribed to
these patients, electronically registered medical records
were assessed. In Denmark, all medical drug prescriptions
for patients in hospitals utilize a computer-based medical
prescription system, where all administered drugs are doc-
umented. Hence, a dosage of a drug cannot be adminis-
tered to a patient without electronic registration.
Data from prescribed postoperative analgesics were
used for patients operated at six major colorectal surgery
centers in eastern Denmark. All centers had specific
local guidelines for postoperative analgesic treatment.
The same cohort used in this study has been described
previously [8], however with a different focus and data
analyses. Patients were included if having available elec-
tronic medical records and if having received an elective
operation between January 1, 2006 and December 31,
2009 for either colonic or rectal cancer with a primary
anastomosis.
A pre-study evaluation found that 0.4% of the patients
in this study population received other NSAIDs than
ibuprofen and diclofenac. Thus, we chose to focus the
study on these two drugs as part of the multimodal
postoperative pain treatment. Hence, other opioid spar-
ing drugs, such as alternative NSAIDs or paracetamol,
were not evaluated. Data for the postoperative NSAID
consumption were collected from electronic medical re-













Figure 1 The percentages at the different departments using NSAIDsthe medication was prescribed and actually taken by the
patient. The following variables were registered:
 Use of the NSAIDs ibuprofen or diclofenac as part
of the postoperative analgesic regimen (yes/no).
 The type of NSAID
 Whether the patients receiving NSAID, received a
pre-defined dose of the specific drug as a minimum.
For ibuprofen, this dosage was defined as 800 mg/
day for at least two days and for diclofenac, the
dosage use was defined as 50 mg/day for at least
two days.
 NSAIDs used as p.r.n.
Patients’ age and dosage of NSAIDs were reported as
median (range), since these data were not normally dis-
tributed. Remaining variables were reported as percent-
ages. Chi-square test was used to evaluate the distribution
of dichotomous outcomes between departments, whereas
Kruskal-Wallis test was used to compare dosages of
NSAIDs between departments. A p-value less than 0.05
was regarded statistically significant. SPSS version 19
(SPSS Inc, Chicago, Illinois, USA) was used for statis-
tical analyses.
Approval was obtained from the Danish data protection
agency (license number 2008-41-2484). The study was not
eligible for ethics committee approval according to Danish
law, since we had no contact with patients, did not per-
form any interventions or used biological material.Results
The patients had a median age of 70 years with an equal
distribution between genders (Table 1).
Of the 2,754 patients, 40.6% (1,117) received NSAIDs as
part of their postoperative analgesic treatment. When eval-
uated on department level, there was a wide variation
between departments in the use of NSAIDs (p < 0.001,


























NSAID used in a pre-defined dosage as a minimum
Figure 2 The percentages at the different departments using
NSAIDs in a pre-defined dosage as a minimum.
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NSAIDs.
The percentage of the patients receiving NSAIDs
who received the pre-defined dosage as a minimum
was also different between the departments (p < 0.001,
chi-square test), (Figure 2). For department 1 and
partly for department 3, NSAIDs were generally used
below this dosage. However, in the remaining depart-
ments the majority of patients received the pre-defined
dosage of NSAIDs.
The type of NSAID used differed between depart-
ments (p < 0.001, chi-square test). However, most depart-
ments used ibuprofen in the majority of the patients
except for department 6, in which diclofenac was used
in more than 80% of the patients (Tables 2 and 3).
Of the patients receiving the pre-defined dosage of
NSAIDs as a minimum, the specific daily dosage differed
between the departments (p = 0.025, Kruskal-wallis test),
with a median dosage of 1200 mg (400–2,400 mg) for
ibuprofen for all departments (Table 2). For diclofenac,
the median dosage was 100 mg (50–200 mg), with a
statistically significant difference between departments
(p < 0.001, Kruskal-wallis test), (Table 3).
Of the patients receiving NSAIDs, departments dif-
fered in whether NSAIDs were used as p.r.n. medication
in contrast to regular medication (p < 0.001, chi-square
test), (Figure 3). Department 1 used NSAIDs as p.r.n.
medication frequently. However, this use was less pro-
nounced in the other departments.Table 2 Median and range for ibuprofen doses used in the di
Department 1 2
Number of patients 79 5
Percentage of total NSAID use 83,3% 77,5%
Dosage (median) 1,200 1,600
Range 400–1,800 1,200–1,800Discussion
This study found that use of NSAIDs as a part of the
postoperative analgesic regimen differed widely both
between and within colorectal surgery departments in
eastern Denmark. Moreover, the type of NSAID differed
between the departments. However, ibuprofen was the
primary NSAID used.
The variation in the use of NSAIDs, the dosage and
the type between departments may reflect conflicting
guidelines in the different departments. Thus, there is ob-
viously a lack of consensus on the proper postoperative
analgesic regimen to use, at least concerning NSAIDs.
Procedure specific regimens for patients operated with
colorectal resection have been proposed [9,10]. Such
guidelines should be based on the best available evidence
and whether they are implemented into clinical practice
may depend on the quality of that evidence and the dis-
semination of knowledge to the clinicians.
Even though each department in the study had local
guidelines, a variation in the use of NSAIDs was ob-
served within the departments. This may be a result of
the clinicians not fully adhering to the guidelines, possibly
due to concern of adverse effects, or that the clinicians
were not completely informed about these. In Denmark,
pre-specified analgesic regimens may be available in the
electronic medical systems. However, it has been shown
that actual instructions in form of written procedure spe-
cific guidelines seldom exist in departments [5]. The range
of the prescribed doses shows that some of departments
administrated quite low doses (400 mg for Ibuprofen) of
NSAID to the patients. If the administration of such a low
dosage reflects what was prescribed, this may illustrate a
lack of knowledge about proper dosage of NSIAD among
clinicians and therefore education may be needed. How-
ever, the variation may also be explained by discrepancies
between the medication prescribed and the medication ac-
tually given to the patients. In situations where the patient
is not in pain, patients or caregiver may think that the pre-
scribed medication may not be necessary. However, there
are good reasons to give analgesics even during a period
without pain in order to prevent break-through pain [11].
One of the main reasons to use multimodal analgesic
post-operative treatment is to reduce opioid consump-
tion and thereby limit opioid induced nausea and otherfferent departments
3 4 5 6
296 203 40 30
96,1% 99,0% 88,9% 14,1%
1,200 1,600 1,200 1,200
400–1,800 800–2,400 800–1,800 600–1,800
Table 3 Median and range for diclofenac doses used in the different departments
Department 1 2 3 4 5 6
Number of patients 23 1 12 2 5 183
Percentage of total NSAID use 16,7% 22,5% 3,9% 1,0% 11,1% 85,9%
Dosage (median) 150 50 100 125 150 100
Range 150–200 NA 50–150 100–150 100–200 75–200
NA: not applicable.
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have shown that patients do not receive multimodal pain
treatment to a sufficient degree [2,5,12].
NSAIDs are commonly used as part of a multimodal
analgesic regimen [10,13]. However, it has been ques-
tioned whether NSAIDs may have detrimental effects for
patients receiving colorectal anastomoses. Despite this,
such regimens are recommended after colorectal surgery
[9,10,13], but no consensus exists on which type of NSAID
to use. In some guidelines, COX-2 selective drugs have
been recommended [9,10]. Nevertheless, other researchers
have banned NSAIDs, such as diclofenac and celecoxib,
due to a possibly increased risk of anastomotic leakage in
the patients in addition to other potential complications
[8,14]. Several studies have shown that these NSAIDs may
increase the risk of anastomotic leakage [8,15,16]. Thus,
there is increasing evidence that these drugs should not
be used for patients receiving colorectal anastomoses. A
recent study suggests that non-selective NSAIDs may be
more harmful than COX-2 selective NSAIDs with regards
to anastomotic leakage [17]. In the present study, diclofenac
was used in a proportion of the patients. However, due to
the recent increased awareness of the negative effects of
this drug, the use of diclofenac may have decreased after
the time period investigated in this study.
The strengths of this study were 100% data com-
pleteness from the electronic medical records and a











Department 1 Department 2 Departmen
Use of postoperat
Figure 3 The percentages at the different departments using NSAIDsactually taken by the patients. However, we only evalu-
ated ibuprofen and diclofenac, and other opioid spar-
ing drugs, such as paracetamol, were not evaluated in
this study. We evaluated the daily dose of the NSAIDs
and whether the drug was given for more or less than
two days. However, the precise number of days was not
recorded.
As described earlier, procedure specific guidelines
already exist for colorectal surgery [10,13]. However,
quality of the evidence for many specific procedures,
including colorectal surgery, is still not sufficient. The
evidence for an additive or synergistic effect of various
drug combinations is sparse, as is the evidence for particu-
lar dosages. A basic recipe for post-operative analgesia
should be defined based on evidence from large-scale
studies concerning safety and efficacy.Conclusion
In conclusion, large variations in the use of postoperative
NSAIDs exist both between and within departments. This
points to an inconsistency in the use of multimodal
postoperative pain treatments and a lack of consensus on
the treatment regimens, and may be a result of insufficient
evidence on procedure specific pain treatments. Thus,
large-scale studies are needed to produce guidelines for
post-operative analgesic treatment based on high-quality
evidence.t 3 Department 4 Department 5 Department 6
ive NSAID as p.r.n.
as p.r.n. in their postoperative pain treatment.
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